Literature DB >> 9658734

T-cell acute lymphoblastic leukemia occurring in a patient with acute promyelocytic leukemia.

V Liso1, G Specchia, A Pannunzio, A Mestice, G Palumbo, A Biondi.   

Abstract

Secondary acute lymphoblastic leukemia (sALL) following acute myeloid leukemia (AML) is a rare event; only eight cases have been reported. We report a patient with acute promyelocytic leukemia (APL), in hematological and molecular remission who developed T-ALL three years after the diagnosis of APL. The morphological, cytochemical, phenotypical and molecular features of this T-ALL were different from those of the previous APL. The absence of t(15;17), negative PML/RAR alpha at reverse transcription polymerase chain reaction (RT-PCR) analysis and presence of TcR delta support the hypothesis that the T-ALL in this sALL case originated from a different clone from that of the APL cells.

Entities:  

Mesh:

Year:  1998        PMID: 9658734

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  5 in total

Review 1.  A focused review of hematopoietic neoplasms occurring in the therapy-related setting.

Authors:  Liping Zhang; Sa A Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

2.  The TCR γδ repertoire and relative gene expression characteristics of T-ALL cases with biclonal malignant Vδ1 and Vδ2 T cells.

Authors:  Haitao Zheng; Xu Wang; Yu Ma; Bing Xu; Shaohua Chen; Lijian Yang; Xiuli Wu; Grzegorz K Przybylski; Suming Huang; Tiezhen Ye; Yangqiu Li
Journal:  DNA Cell Biol       Date:  2013-12-13       Impact factor: 3.311

3.  Myeloid leukemia with transdifferentiation plasticity developing from T-cell progenitors.

Authors:  Pia Riemke; Melinda Czeh; Josephine Fischer; Carolin Walter; Saeed Ghani; Matthias Zepper; Konstantin Agelopoulos; Stephanie Lettermann; Marie L Gebhardt; Nancy Mah; Andre Weilemann; Michael Grau; Verena Gröning; Torsten Haferlach; Dido Lenze; Ruud Delwel; Marco Prinz; Miguel A Andrade-Navarro; Georg Lenz; Martin Dugas; Carsten Müller-Tidow; Frank Rosenbauer
Journal:  EMBO J       Date:  2016-08-29       Impact factor: 11.598

4.  T-cell acute lymphoblastic leukemia as a secondary leukemia after a 3-year remission of acute myelocytic leukemia.

Authors:  Kazuya Tsuboi; Hirokazu Komatsu; Hiroshi Miwa; Shinsuke Iida; Shougo Banno; Atsushi Wakita; Masakazu Nitta; Ryuzo Ueda
Journal:  Int J Hematol       Date:  2003-06       Impact factor: 2.490

5.  A case of T-cell acute lymphoblastic leukemia after treatment of acute promyelocytic leukemia.

Authors:  P C Bee; G G Gan; J V Sangkar; A Teh; K Y Goh
Journal:  Int J Hematol       Date:  2004-05       Impact factor: 2.490

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.